During inflammatory processes, such as obesity, the excessive production of IL-6 can lead to chronic activation of the trans-signaling pathway, thereby favoring insulin resistance and contributing to the development of metabolic diseases [113]. This evidence concerns the gene IL6 and obesity disorder.